Advagene Biopharma Co (ROCO:6709) EPS (Basic) : NT$-1.83 (TTM As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Advagene Biopharma Co EPS (Basic)?

Advagene Biopharma Co's basic earnings per share (Basic EPS) for the six months ended in Jun. 2023 was NT$-0.93. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-1.83.

Advagene Biopharma Co's EPS (Diluted) for the six months ended in Jun. 2023 was NT$-0.93. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-1.83.

Advagene Biopharma Co's EPS without NRI for the six months ended in Jun. 2023 was NT$-0.93. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2023 was -1.83.

During the past 3 years, the average EPS without NRI Growth Rate was -5.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 5.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Advagene Biopharma Co's highest 3-Year average EPS without NRI Growth Rate was 30.60% per year. The lowest was -5.40% per year. And the median was 15.40% per year.

Advagene Biopharma Co EPS (Basic) Historical Data

The historical data trend for Advagene Biopharma Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advagene Biopharma Co EPS (Basic) Chart

Advagene Biopharma Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

-2.05

-1.57

-1.88

-2.40

-1.83

Advagene Biopharma Co Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EPS (Basic)	Get a 7-Day Free Trial										-1.06	-1.12	-1.28	-0.93	-0.90

Advagene Biopharma Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Advagene Biopharma Co's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-92.11	-	0)	/	50.333
	=	-1.83

Advagene Biopharma Co's Basic EPS for the quarter that ended in Jun. 2023 is calculated as

Basic EPS (Q: Jun. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-46.629	-	0)	/	49.796
	=	-0.94

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-1.83

Advagene Biopharma Co (ROCO:6709) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Advagene Biopharma Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Advagene Biopharma Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Advagene Biopharma Co (ROCO:6709) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advagene Biopharma Co Ltd (ROCO:6709) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sector 1, Neihu Road, 6 Floor, No.308, Neihu District, Taipei, TWN, 114

Website

http://www.advagene.com.tw

Advagene Biopharma Co Ltd is a Taiwan based immune-modulatory platform-based drug developer. The company has completed technology transfer with DCB for detoxified LT Adjuvant Technology Platform. Its product development includes nasal spray influenza vaccine (LT-Flu), allergy vaccines (LT-Allergy), and other vaccines.

Advagene Biopharma Co (ROCO:6709) Headlines

No Headlines